Oncology Trial Success
Our customer was conducting a Phase III Oncology clinical trial. The initial request was for local sourcing over 80 countries.
We at ADAllen Pharma believe that we can be justifiably proud of the work we put in, and our willingness to pull out all the stops to fulfil orders and meet our customers’ requirements, even those that might seem virtually unachievable. Take a look at these case studies to get an idea of the resourcefulness, sheer hard work and attention to detail we deploy in satisfying our customers’ requests, while never allowing the need for speed to compromise our insistence on maintaining the highest quality standards.
Our customer was conducting a Phase III Oncology clinical trial. The initial request was for local sourcing over 80 countries.
Our customer had asked for numerous ancillary products and Oncology cold chain products to be shipped to different depots on a number of restrictive borders.
Our Customer was conducting a Global Phase II trial; the product required was a high value disease-modifying drug that was tightly watched by manufacturer
A contract research organization (CRO) had used our services to procure Viagra for a recent clinical trial.
Bio Similar Case Study. Through our approved supplier source, we were able to secure a high value drug, within the time scale allotted for the trial.
Our customer was looking for a particular size of sterile vial for use in a clinical trial.
A client we had been supplying for several years asked us to source over a million capsules of a drug from a specific European country in a single batch.
We were asked to source a recently launched diabetes product they had found impossible to obtain. In addition, they required the drug in a dosage form that was in short supply.
We were approached with a request for a specialised product that he said was available only in Italy. Our customer was unsure of the product details with regard to strength, pack size and storage conditions.
We were asked to source comparators for a multi-country clinical trial. Initially the specification was for US and various European formulations of a marketed drug.